Beranda › Makroglobulinemia Waldenstrom › Massachusetts › Boston
Uji klinis Makroglobulinemia Waldenstrom di Boston, MA
9 studi untuk Makroglobulinemia Waldenstrom mencari peserta di lokasi sekitar Boston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
Menerima pesertaFase 2
- Dana Farber Cancer Institute (Data Collection and Specimen Analysis), Boston
- Beth Israel Deaconess Medical Center (Data Collection Only), Boston
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Menerima pesertaFase 1/2
- Dana Farber Cancer Institute, Boston
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Menerima pesertaFase 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM
Menerima pesertaFase 2
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Menerima pesertaFase 4
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Menerima pesertaStudi observasional
- Dana-Farber Cancer Institute, Boston
Epcoritamab in Previously Treated WM
Menerima pesertaFase 2
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Study of SGR-1505 in Mature B-Cell Neoplasms
Menerima pesertaFase 1
- Beth Israel Deaconess Medical Center, Boston
A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia
Menerima pesertaFase 2
- Dana Farber Cancer Institute, Boston
Uji klinis Makroglobulinemia Waldenstrom di kota lain
- Durham, NC10 studi
- Denver, CO7 studi
- New York City, NY6 studi
- Edison, NJ6 studi
- Dallas, TX6 studi
- Houston, TX6 studi
- Seattle, WA5 studi
- Rochester, MN5 studi
- Milwaukee, WI5 studi
- Queens, NY4 studi
- Columbus, OH4 studi
- Baldwin Park, CA4 studi
Studi lain di Boston
- Kanker Payudara111 studi
- Kanker Paru Non-Sel Kecil90 studi
- Kanker (semua jenis)86 studi
- Kanker Kolorektal63 studi
- Kanker Metastatik63 studi
- Kanker Paru62 studi
- Kanker Ovarium61 studi
- Kanker Prostat59 studi
- Depresi52 studi
- Kanker Endometrium50 studi
- Gagal Jantung44 studi
- Leukemia Mieloid Akut44 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.